Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 8% | 8.2% | 15.1% |
| Success rate | 100% | 68% | 82% |
| Transactions |
3
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Executive Chairman of the Board | Invitae Corp | Jan. 9, 2017 - |
| Independent Director | BridgeBio Pharma Inc | June 23, 2020 - |
| Executive Chairman of the Board | Invitae Corp | Jan. 9, 2017 - Sept. 1, 2019 |
| Chairman of the Board, Chief Executive Officer | Invitae Corp | Aug. 1, 2012 - Jan. 9, 2017 |
| Chief Executive Officer of InVitae Corporation, Director | Genomic Health Inc | March 1, 2012 - Aug. 8, 2012 |
| Director | Invitae Corp | Jan. 1, 2010 - Aug. 1, 2012 |
| Executive Chairman of the Board | Genomic Health Inc | Jan. 1, 2009 - March 1, 2012 |
Search